Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

EyePoint Pharmaceuticals Inc. buy Jefferies Financial Group Inc.

Start price
€4.06
17.08.26 / 50%
Target price
€6.91
17.08.27
Performance (%)
16.26%
Price
€11.40
14.08.26
Summary
This prediction is currently active. The prediction currently has a performance of 16.26%. This prediction currently runs until 17.08.27. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this prediction
Performance without dividends (%)
Name 1w
EyePoint Pharmaceuticals Inc. 16.26%
iShares Core DAX® -0.046%
iShares Nasdaq 100 0.922%
iShares Nikkei 225® 3.014%
iShares S&P 500 -0.359%

Comments by Jefferies_Financial_ for this prediction

In the thread EyePoint Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 16.26%
Target price 6.909
Change
Ends at 17.08.27

Eyepoint Pharmaceuticals (EYPT) had its price target lowered by Jefferies Financial Group Inc. from $30.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for EYPT provided by MarketBeat

Stopped prediction by Jefferies_Financial_ for EyePoint Pharmaceuticals Inc.

buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.42
28.08.24
€13.50
28.08.25
16.06%
29.08.25